BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 27731450)

  • 1. Folic acid conjugated Fe
    Rana S; Shetake NG; Barick KC; Pandey BN; Salunke HG; Hassan PA
    Dalton Trans; 2016 Nov; 45(43):17401-17408. PubMed ID: 27731450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fabrication and spectroscopic studies of folic acid-conjugated Fe3O4@Au core-shell for targeted drug delivery application.
    Karamipour Sh; Sadjadi MS; Farhadyar N
    Spectrochim Acta A Mol Biomol Spectrosc; 2015 Sep; 148():146-55. PubMed ID: 25879984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermal and pH responsive polymer-tethered multifunctional magnetic nanoparticles for targeted delivery of anticancer drug.
    Sahoo B; Devi KS; Banerjee R; Maiti TK; Pramanik P; Dhara D
    ACS Appl Mater Interfaces; 2013 May; 5(9):3884-93. PubMed ID: 23551195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of magnetic gold nanoparticles to be used as doxorubicin nanocarriers.
    Elbialy NS; Fathy MM; Khalil WM
    Phys Med; 2014 Nov; 30(7):843-8. PubMed ID: 24950615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pH-responsive folate conjugated magnetic nanoparticle for targeted chemo-thermal therapy and MRI diagnosis.
    Gupta J; Mohapatra J; Bhargava P; Bahadur D
    Dalton Trans; 2016 Feb; 45(6):2454-61. PubMed ID: 26685824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Environmentally Responsive Dual-Targeting Nanoparticles: Improving Drug Accumulation in Cancer Cells as a Way of Preventing Anticancer Drug Efflux.
    Daglioglu C
    J Pharm Sci; 2018 Mar; 107(3):934-941. PubMed ID: 29107049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polylactide-based Magnetic Spheres as Efficient Carriers for Anticancer Drug Delivery.
    Mhlanga N; Sinha Ray S; Lemmer Y; Wesley-Smith J
    ACS Appl Mater Interfaces; 2015 Oct; 7(40):22692-701. PubMed ID: 26390359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of biocompatible nanocrystalline cellulose against folate receptors as a novel carrier for targeted delivery of doxorubicin.
    Karimian A; Yousefi B; Sadeghi F; Feizi F; Najafzadehvarzi H; Parsian H
    Chem Biol Interact; 2022 Jan; 351():109731. PubMed ID: 34728188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and construction of multifunctional hyperbranched polymers coated magnetite nanoparticles for both targeting magnetic resonance imaging and cancer therapy.
    Mashhadi Malekzadeh A; Ramazani A; Tabatabaei Rezaei SJ; Niknejad H
    J Colloid Interface Sci; 2017 Mar; 490():64-73. PubMed ID: 27870961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of Cross-linked Poly (N-isopropylacrylamide) Magnetic Nano Composite for Application in the Controlled Release of Doxorubicin.
    Kaamyabi S; Badrian A; Akbarzadeh A
    Pharm Nanotechnol; 2017; 5(1):67-75. PubMed ID: 28948911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of Anticancer Drug Release by Cobalt Ferrite Magnetic Nanoparticles through Combined pH and Temperature Responsive Technique.
    Dey C; Ghosh A; Ahir M; Ghosh A; Goswami MM
    Chemphyschem; 2018 Nov; 19(21):2872-2878. PubMed ID: 30133086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of surface functionalized hydroxyapatite nanoparticles for enhanced specificity towards tumor cells.
    Verma G; Shetake NG; Pandrekar S; Pandey BN; Hassan PA; Priyadarsini KI
    Eur J Pharm Sci; 2020 Mar; 144():105206. PubMed ID: 31870813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functionalized magnetic dextran-spermine nanocarriers for targeted delivery of doxorubicin to breast cancer cells.
    Tarvirdipour S; Vasheghani-Farahani E; Soleimani M; Bardania H
    Int J Pharm; 2016 Mar; 501(1-2):331-41. PubMed ID: 26875475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pH sensitive surfactant-stabilized Fe
    Dutta B; Shetake NG; Barick BK; Barick KC; Pandey BN; Priyadarsini KI; Hassan PA
    Colloids Surf B Biointerfaces; 2018 Feb; 162():163-171. PubMed ID: 29190467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-functional nanocarriers based on iron oxide nanoparticles conjugated with doxorubicin, poly(ethylene glycol) and folic acid as theranostics for cancer therapy.
    Rajkumar S; Prabaharan M
    Colloids Surf B Biointerfaces; 2018 Oct; 170():529-537. PubMed ID: 29966906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxorubicin-conjugated core-shell magnetite nanoparticles as dual-targeting carriers for anticancer drug delivery.
    Sadighian S; Rostamizadeh K; Hosseini-Monfared H; Hamidi M
    Colloids Surf B Biointerfaces; 2014 May; 117():406-13. PubMed ID: 24675279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutamic acid-coated Fe
    Dutta B; Nema A; Shetake NG; Gupta J; Barick KC; Lawande MA; Pandey BN; Priyadarsini IK; Hassan PA
    Mater Sci Eng C Mater Biol Appl; 2020 Jul; 112():110915. PubMed ID: 32409067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin loaded magnetic gold nanoparticles for in vivo targeted drug delivery.
    Elbialy NS; Fathy MM; Khalil WM
    Int J Pharm; 2015 Jul; 490(1-2):190-9. PubMed ID: 25997662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
    Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
    Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation, characterization and in vitro anticancer activity of paclitaxel conjugated magnetic nanoparticles.
    Tarantash M; Nosrati H; Kheiri Manjili H; Baradar Khoshfetrat A
    Drug Dev Ind Pharm; 2018 Nov; 44(11):1895-1903. PubMed ID: 30073853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.